The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC).
T. Franchina
No relevant relationships to disclose
N. Ferlazzo
No relevant relationships to disclose
F. Colonese
No relevant relationships to disclose
E. Alafaci
No relevant relationships to disclose
A. D' Aquino
No relevant relationships to disclose
G. Ferraro
No relevant relationships to disclose
C. Garipoli
No relevant relationships to disclose
C. Maisano
No relevant relationships to disclose
M. Picciotto
No relevant relationships to disclose
M. CurrĂ²
No relevant relationships to disclose
R. Ientile
No relevant relationships to disclose
V. Adamo
No relevant relationships to disclose